Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02203747 · ClinicalTrials.gov registry record
Patient Perception of Visual Distortions
A clinical trial, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- 79
- Enrollment target
NCT02203747: Completed study, sponsored by Abbott Medical Optics.
NCT02203747 is a clinical trial that has completed, run by Abbott Medical Optics. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02203747 has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate visual distortions reported by pseudophakic patients.
Primary Outcome
Subjective rating of visual distortion symptoms under overall conditions at baseline. Rating scale consisted of the following categories: "did not experience" (rating = 0), "mild" (rating = 1), "moderate" (rating = 2), or "severe" (rating = 3), therefore, the lower values represent the best outcome. The minimum score was 0 and the maximum score was 3.
Interventions
- OTHER Administration of patient self-assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-01 |
What the finished NCT02203747 record still lists
NCT02203747 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Administration of patient self-assessment is the first listed.
NCT02203747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02203747 about?
NCT02203747 is a clinical study titled "Patient Perception of Visual Distortions". The purpose of this study is to evaluate visual distortions reported by pseudophakic patients.
What is the current status of trial NCT02203747?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2014-08. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02203747?
The interventions under investigation include: Administration of patient self-assessment (OTHER).
Who is sponsoring clinical trial NCT02203747?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia